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Background and aim
Systemic lupus erythematosus (SLE) have accelerated
atherosclerosis and increased risk of cardiovascular dis-
ease. It is thought that the atherosclerosis process begins
in the first decades of life and progresses silently. The aim
of this study is to evaluate subclinical cardiovascular
abnormalities including atherosclerosis and left ventricular
hypertrophy (LVH) in children and adolescent with SLE.
Methods
Non-invasive cardiovascular assessments were made on 22
patients with juvenile SLE (20 girls, aged 15.0 ± 2.7 years)
with GFR ≥90 ml/min/1.73 m
2, following in a single center.
Ambulatory blood pressure monitoring (ABPM) was used
for the definition of hypertension. Ultrasonographic exami-
nations of the heart and carotid artery were performed to
evaluate LVH, carotid intima-media thickness (IMT) and
carotid artery distensibility. Aortic (carotid-femoral) pulse
wave velocity (PWV) and pulse wave analysis (PWA) were
also performed for the assessment of arterial stiffness. To
compare the PWV and PWA of the patients, two control
groups were formed; matched for age/sex (control A;
n=22) and for height/sex (control H; n=22).
Results
The median disease duration was 39.5 (iqr 26.0-65.2)
months. Twenty patients fulfilled four or more of the SLE
ACR criteria for SLE classification; 2 patients had 3 criteria.
Twelve patients had active disease characterized by SLE-
DAI ≥3 and none of the patients had organ damage as
identified by SLICC. Eight patients (36%) had hypertension
according to the ABPM measurements. The mean left ven-
tricular mass (LVM) index was 37.5 ± 11.2 g/m
2.7;6
patients (27%) had LVH as LVM index >38 g/m
2.7.T h e
mean carotid IMT was 0.46 ± 0.06 mm, carotid IMT-SDS
was 2.03 ± 1.68. Twelve patients (54%) showed increased
carotid IMT. Patients had higher aortic PWV (5.32 ± 0.87
m/s) compared to both control groups (4.98 ± 0.45 m/s for
control A, and 4.84 ± 0.38 m/s for control H); however the
difference was significant only for control H (p= 0.041).
Aortic PWV was found to be correlated with average index
SBP on ABPM (r=0.74, p< 0.001) and BMI-SDS (r=0.41,
p=0.036). No correlation was found between PWV and
laboratory parameters including s-CRP, ESR, C3,C 4, anti-
ds DNA, ACP IgM or ACP IgG levels. PWV showed a sig-
nificant association with carotid distensibility calculated
from carotid end-diastolic and peak systolic internal
dimensions from the M-mode images of carotid artery (r=-
0.57, p=0.007). Aortic augmented pressure and augmenta-
tion index (AI) were similar in patients and controls.
Conclusion
Patients with juvenile onset SLE, even without organ
damage (SLICC=0), had an evidence of early athero-
sclerosis and increased left ventricular mass. Our result
suggested that subclinical cardiovascular disease begins
in the early years of life. We conclude that early identifi-
cation of subclinical cardiovascular abnormalities is
important to reduce overt cardiovascular disease in
patients with SLE.
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